Deutsche Bank’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Deutsche Bank’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-17,948	Closed	-$834K	–	3918
2023 Q2	$834K	Sell	17,948 -5,742	-24%	-$198K	﹤0.01%	2081
2023 Q1	$679K	Buy	23,690 +6,554	+38%	+$194K	﹤0.01%	2319
2022 Q4	$535K	Buy	17,136 +5,602	+49%	+$183K	﹤0.01%	2414
2022 Q3	$234K	Sell	11,534 -1,890	-14%	-$34.4K	﹤0.01%	2853
2022 Q2	$208K	Buy	13,424 +5,368	+67%	+$92.3K	﹤0.01%	3143
2022 Q1	$154K	Sell	8,056 -407	-5%	-$7.26K	﹤0.01%	3402
2021 Q4	$214K	Buy	+8,463	New	+$248K	﹤0.01%	3356

Deutsche Bank's DICE Position: Q3 2023 in Review

Deutsche Bank sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 17,948 shares — an estimated $834K sold.

Deutsche Bank first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $834K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Deutsche Bank reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Deutsche Bank sold 17,948 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $834K.
Deutsche Bank first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Deutsche Bank's DICE Therapeutics, Inc. Common Stock position peaked at $834K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.